Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Xcellerated T Cells After Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Myeloma

NCT00048464 is registered in ClinicalTrials.gov with Xcyte Therapies as lead sponsor.

NCT NCT00048464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00048464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Xcellerated T Cells After Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Myeloma
Lead sponsor
Xcyte Therapies
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 31, 2002
Completion date
Not reported
Enrollment
35
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma